MDR/IVDR reforms require adoption by the European Parliament, referencing US FDA pre-submission meetings.
Steady: 0 in the last 7 days
Updated oct 8
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MDR/IVDR reforms require adoption by the European Parliament, referencing US FDA pre-submission meetings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Institutions published updated pharmaceutical legislation text on October 8, 2026.Sub-event
EU regulatory reforms (MDR/IVDR) require Parliament adoption and reference FDA meetings.1 source
Keep exploring
The entities involved
-
European Commission
executive branch of the European Union
- Europe is exploring the economic potential of its space and navigation systems, including Galileo, with involvement from the European Commission and the European Investment Bank.
- EU and Canada are deepening their partnership, with the EU pledging funding for oceanographic research and Costa launching a multilateralism forum.
-
European Parliament
parliament of the European Union directly elected by the citizens of the Union
- FDA
Related events
- Both the FDA and the European Medicines Agency govern drug approval processes.
- Both the FDA and European Medicines Agency must adopt evidence-based principles for drug regulation.
- FDA confirmed CMC and device plans are Phase 3 ready, coinciding with strengthening of US and EU patent estates.
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
- New FDA rule threatens the ability to import medicines.